Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10356084rdf:typepubmed:Citationlld:pubmed
pubmed-article:10356084lifeskim:mentionsumls-concept:C0008865lld:lifeskim
pubmed-article:10356084lifeskim:mentionsumls-concept:C0008377lld:lifeskim
pubmed-article:10356084lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:10356084lifeskim:mentionsumls-concept:C0032105lld:lifeskim
pubmed-article:10356084lifeskim:mentionsumls-concept:C0205054lld:lifeskim
pubmed-article:10356084lifeskim:mentionsumls-concept:C0001374lld:lifeskim
pubmed-article:10356084lifeskim:mentionsumls-concept:C0030016lld:lifeskim
pubmed-article:10356084lifeskim:mentionsumls-concept:C0040676lld:lifeskim
pubmed-article:10356084lifeskim:mentionsumls-concept:C0439962lld:lifeskim
pubmed-article:10356084lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:10356084lifeskim:mentionsumls-concept:C0441994lld:lifeskim
pubmed-article:10356084lifeskim:mentionsumls-concept:C0005492lld:lifeskim
pubmed-article:10356084lifeskim:mentionsumls-concept:C2828366lld:lifeskim
pubmed-article:10356084lifeskim:mentionsumls-concept:C1705851lld:lifeskim
pubmed-article:10356084lifeskim:mentionsumls-concept:C1555707lld:lifeskim
pubmed-article:10356084lifeskim:mentionsumls-concept:C2752151lld:lifeskim
pubmed-article:10356084pubmed:issue6lld:pubmed
pubmed-article:10356084pubmed:dateCreated1999-6-24lld:pubmed
pubmed-article:10356084pubmed:abstractTextThe cholesterol-lowering effects of tangerine peel extract and a mixture of two citrus flavonoids were tested. Male rats were fed a 1 g/100 g high-cholesterol diet for 42 d with supplements of either tangerine-peel extract or a mixture of naringin and hesperidin (0.5 g/100 g) to study the effects of plasma and hepatic lipids, hepatic enzyme activities, and the excretion of fecal neutral sterols. Both the tangerine-peel extract and mixture of two flavonoids significantly lowered the levels (mean +/- SE) of plasma (2.44 +/- 0. 59 and 2.42 +/- 0.31 mmol/L, vs. 3.80 +/- 0.28 mmol/L, P < 0.05), hepatic cholesterol (0.143 +/- 0.017 and 0.131 +/- 0.010 mmol/g vs. 0.181 +/- 0.003 mmol/g, P < 0.05), and hepatic triglycerides (0.069 +/- 0.007 and 0.075 +/- 0.006 mmol/g vs. 0.095 +/- 0.002 mmol/g, P < 0.05) compared to those of the control. The 3-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) reductase (1565.0 +/- 106. 0 pmol. min-1. mg protein-1 and 1783.0 +/- 282 pmol. min-1. mg protein-1 vs. 2487.0 +/- 210.0 pmol. min-1. mg protein-1, P < 0.05) and acyl CoA: cholesterol O-acyltransferase (ACAT) activities (548.0 +/- 65.0 and 615.0 +/- 80.0 pmol. min-1. mg protein-1 vs. 806.0 +/- 105.0 pmol. min-1. mg protein-1, P < 0.05) were significantly lower in the experimental groups than in the control. These supplements also substantially reduced the excretion of fecal neutral sterols compared to the control (211.1 +/- 26.7 and 208.2 +/- 31.6 mg/d vs. 521.9 +/- 53.9 mg/d). The inhibition of HMG-CoA reductase and ACAT activities resulting from the supplementation of either tangerine-peel extract or a combination of its bioflavonoids could account for the decrease in fecal neutral sterol that appears to compensate for the decreased cholesterol biosynthesis in the liver.lld:pubmed
pubmed-article:10356084pubmed:languageenglld:pubmed
pubmed-article:10356084pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10356084pubmed:citationSubsetIMlld:pubmed
pubmed-article:10356084pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10356084pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10356084pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10356084pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10356084pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10356084pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10356084pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10356084pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10356084pubmed:statusMEDLINElld:pubmed
pubmed-article:10356084pubmed:monthJunlld:pubmed
pubmed-article:10356084pubmed:issn0022-3166lld:pubmed
pubmed-article:10356084pubmed:authorpubmed-author:LeeS HSHlld:pubmed
pubmed-article:10356084pubmed:authorpubmed-author:BokS HSHlld:pubmed
pubmed-article:10356084pubmed:authorpubmed-author:BaiK TKTlld:pubmed
pubmed-article:10356084pubmed:authorpubmed-author:ChoiM SMSlld:pubmed
pubmed-article:10356084pubmed:authorpubmed-author:ParkY BYBlld:pubmed
pubmed-article:10356084pubmed:authorpubmed-author:SonK HKHlld:pubmed
pubmed-article:10356084pubmed:authorpubmed-author:JeongT STSlld:pubmed
pubmed-article:10356084pubmed:issnTypePrintlld:pubmed
pubmed-article:10356084pubmed:volume129lld:pubmed
pubmed-article:10356084pubmed:ownerNLMlld:pubmed
pubmed-article:10356084pubmed:authorsCompleteYlld:pubmed
pubmed-article:10356084pubmed:pagination1182-5lld:pubmed
pubmed-article:10356084pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10356084pubmed:meshHeadingpubmed-meshheading:10356084...lld:pubmed
pubmed-article:10356084pubmed:meshHeadingpubmed-meshheading:10356084...lld:pubmed
pubmed-article:10356084pubmed:meshHeadingpubmed-meshheading:10356084...lld:pubmed
pubmed-article:10356084pubmed:meshHeadingpubmed-meshheading:10356084...lld:pubmed
pubmed-article:10356084pubmed:meshHeadingpubmed-meshheading:10356084...lld:pubmed
pubmed-article:10356084pubmed:meshHeadingpubmed-meshheading:10356084...lld:pubmed
pubmed-article:10356084pubmed:meshHeadingpubmed-meshheading:10356084...lld:pubmed
pubmed-article:10356084pubmed:meshHeadingpubmed-meshheading:10356084...lld:pubmed
pubmed-article:10356084pubmed:meshHeadingpubmed-meshheading:10356084...lld:pubmed
pubmed-article:10356084pubmed:meshHeadingpubmed-meshheading:10356084...lld:pubmed
pubmed-article:10356084pubmed:meshHeadingpubmed-meshheading:10356084...lld:pubmed
pubmed-article:10356084pubmed:meshHeadingpubmed-meshheading:10356084...lld:pubmed
pubmed-article:10356084pubmed:meshHeadingpubmed-meshheading:10356084...lld:pubmed
pubmed-article:10356084pubmed:meshHeadingpubmed-meshheading:10356084...lld:pubmed
pubmed-article:10356084pubmed:meshHeadingpubmed-meshheading:10356084...lld:pubmed
pubmed-article:10356084pubmed:meshHeadingpubmed-meshheading:10356084...lld:pubmed
pubmed-article:10356084pubmed:year1999lld:pubmed
pubmed-article:10356084pubmed:articleTitlePlasma and hepatic cholesterol and hepatic activities of 3-hydroxy-3-methyl-glutaryl-CoA reductase and acyl CoA: cholesterol transferase are lower in rats fed citrus peel extract or a mixture of citrus bioflavonoids.lld:pubmed
pubmed-article:10356084pubmed:affiliationKorea Institute of Bioscience and Biotechnology, KIST, Yusong, Taejon, 305-333, Korea.lld:pubmed
pubmed-article:10356084pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10356084pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10356084lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10356084lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10356084lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10356084lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10356084lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10356084lld:pubmed